Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Incidence of Dyskalemia in Hypertensive Patients Initiating a Fixed Dose Combination Pill of Telmisartan and Amlodipine

NCT05155436 is registered in ClinicalTrials.gov with National Heart Foundation of Bangladesh as lead sponsor.

NCT NCT05155436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05155436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Incidence of Dyskalemia in Hypertensive Patients Initiating a Fixed Dose Combination Pill of Telmisartan and Amlodipine
Lead sponsor
National Heart Foundation of Bangladesh
Phase
Phase 4
Overall status
Completed
Start date
January 15, 2022
Completion date
March 31, 2023
Enrollment
1,090 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, potassium imbalance